| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 102 |
| 1 | MACITENTAN | 55 |
| 2 | ACETAMINOPHEN | 51 |
| 3 | TADALAFIL | 50 |
| 4 | AMBRISENTAN | 46 |
| 5 | SILDENAFIL CITRATE | 40 |
| 6 | SILDENAFIL | 35 |
| 7 | 0XYGEN | 33 |
| 8 | OXYGEN | 33 |
| 9 | ACETAMINOPHEN 500MG | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFIDEROCOL SULFATE TOSYLATE | 3 | 0.0095 |
| 1 | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE | 1 | 0.0085 |
| 2 | SIPULEUCEL-T | 26 | 0.0045 |
| 3 | HEMIN | 2 | 0.0034 |
| 4 | SOYBEAN OIL | 2 | 0.0029 |
| 5 | SMOFLIPID | 2 | 0.0023 |
| 6 | IRON DEXTRAN | 3 | 0.0020 |
| 7 | EPINASTINE HYDROCHLORIDE | 2 | 0.0018 |
| 8 | BODY CLEANSER | 1 | 0.0014 |
| 9 | EPOPROSTENOL | 18 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 119 |
| 1 | Endothelin Receptor Antagonist [EPC] | 100 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 60 |
| 3 | Corticosteroid [EPC] | 54 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 54 |
| 5 | Osmotic Laxative [EPC] | 42 |
| 6 | Loop Diuretic [EPC] | 40 |
| 7 | Aldosterone Antagonist [EPC] | 28 |
| 8 | Autologous Cellular Immunotherapy [EPC] | 26 |
| 9 | Soluble Guanylate Cyclase Stimulator [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Autologous Cellular Immunotherapy [EPC] | 26 | 0.0045 |
| 1 | Lipid Emulsion [EPC] | 4 | 0.0015 |
| 2 | GLP-2 Analog [EPC] | 16 | 0.0012 |
| 3 | Prostacycline [EPC] | 1 | 0.0011 |
| 4 | Prostacycline Vasodilator [EPC] | 119 | 0.0009 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 26 | 0.0008 |
| 6 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 7 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 8 | Endothelin Receptor Antagonist [EPC] | 100 | 0.0005 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 60 | 0.0004 |